![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
One of their significant offerings is Nimodipine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-353 - Rev 00
This Chemical Type CEP, issued on October 25, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1245 associated with this CEP further emphasizes